ITLN1 and systemic sclerosis: Enhanced omentin levels were observed in patients with SSc as well higher levels of omentin-1 in patients with longer than 7 years disease duration may suggest that this adipokine is involved in the pathomechanisms of SSc as its concentrations are not directly related to BMI, age, and insulin resistance indices (HOMA-IR, fasting insulin levels).